Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Effectiveness of Single-Dose Plerixafor in Enhancing Peripheral Blood Progenitor Cell Yield and Rate of Second Collection in Autologous Transplant

Gerardo Garcia-Salas, David Gomez-Almaguer, Carlos Reta-Cortéz, Antonio Vega Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, José Carlos Jaime-Pérez, César Homero Gutierrez-Aguirre, Luz Tarin-Arzaga, Perla Colunga-Pedraza, Olga Cantu, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 7119.

https://doi.org/10.1182/blood-2024-210532

Published: 2024

Journal Articles

Efficacy of Outpatient Haploidentical Transplantation in Patients with Refractory Hodgkin Lymphoma

Ana Cristina Tejada Vasquez, César Homero Gutierrez-Aguirre, Luis Paulo Ugarte Pelaez, Antonio Vega Mateos, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Perla R. Rocio Colunga-Pedraza, Andres Gomez-De Leon, Olga Cantu, José Carlos Jaime-Pérez, David Gomez-Almaguer

Blood (2024) 144 (Supplement 1): 7395.

https://doi.org/10.1182/blood-2024-209003

Published: 2024

Journal Articles

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Alejandra De las Fuentes-Cepeda, Perla R. Colunga-Pedraza, Héctor Alejandro Vaquera Alfaro, Julia Esther Colunga-Pedraza, Andres Gomez-De Leon, Michelle Morcos, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Antonio Vega Mateos, César Homero Gutierrez-Aguirre, Olga Cantu, Luz Tarin-Arzaga, Consuelo Mancías-Guerra, David Gomez-Almaguer, Guillermo José Ruiz-Arguelles

Blood (2024) 144 (Supplement 1): 7299.

https://doi.org/10.1182/blood-2024-210921

Published: 2024

Journal Articles

Low-Dose Venetoclax with Azacitidine in Adults with Acute Myeloid Leukemia: Impact of Phenotype on Outcomes

Luis Ugarte, Yadith Karina Lopez-Garcia, Fernando De La Garza, Francisco Rubio, Michelle Morcos, Alexia Gonzalez, Ana Cristina Tejada Vasquez, Antonio Vega Mateos, Gerardo Garcia-Salas, Perla R. Colunga-Pedraza, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 5964.

https://doi.org/10.1182/blood-2024-212023

Published: 2024

Journal Articles

Therapy Based on Attenuated Arsenic Trioxide Plus Low-Dose All-Trans-Retinoic Acid in Acute Promyelocytic Leukemia. Is Less More?

Yadith Karina Lopez-Garcia, Edgar Ulises Coronado-Alejandro, Anna Cecilia Rodriguez, Gerardo Garcia-Salas, Antonio Vega Mateos, Ana Cristina Tejada Vasquez, Perla R. Rocio Colunga-Pedraza, Luz Tarin-Arzaga, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 6044.

https://doi.org/10.1182/blood-2024-208802

Published: 2024

Journal Articles

Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study

Yadith Karina Lopez-Garcia, Sara Redondo Velao, Andres Gomez-De Leon, Irene García-Cadenas, Héctor Alejandro Vaquera Alfaro, Perla R. Colunga-Pedraza, Albert Esquirol, César Homero Gutierrez-Aguirre, José Carlos Jaime-Pérez, Jorge Sierra, Olga Cantu, Javier Briones, David Gomez-Almaguer, Rodrigo Martino

Blood (2024) 144 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2024-210332

Published: 2024

Journal Articles

Identifying Barriers to Sexual Health in Patients with Hematological Malignancies and Underprivileged Circumstances

Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, Luis Paulo Ugarte Pelaez, Yadith Karina Lopez-Garcia, Antonio Vega Mateos, Perla R. Colunga-Pedraza, Luz Tarin-Arzaga, Andres Gomez-De Leon, Olga Cantu, Jose Carlos Jaime-Pérez, David Gomez-Almaguer

Blood (2024) 144 (Supplement 1): 2364.

https://doi.org/10.1182/blood-2024-208836

Published: 2024

Journal Articles

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Antonio Vega Mateos, Héctor Alejandro Vaquera Alfaro, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Olga Cantu, Andres Gomez-De Leon, David Gomez-Almaguer, Luz Tarin-Arzaga, César Homero Gutierrez-Aguirre, Perla R. Colunga-Pedraza

Blood (2024) 144 (Supplement 1): 1665.

https://doi.org/10.1182/blood-2024-208831

Published: 2024

Journal Articles

The Impact of Adding Rituximab to the Standard Chemotherapy + TKI Regimen in Adults with Philadelphia-Positive B Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study

Sergio Rodriguez-Rodriguez, Fausto Alfredo Rios Olais, Analy Mora, Christian Omar Ramos Peñafiel, Victor Itaí Urbalejo Ceniceros, Yadith Karina Lopez-Garcia, Andres Gomez-De Leon, Nancy Delgado-López, Mistral Castellanos Mares, Patricia Carolina Figueroa Hernandez, Roberta Demichelis

Blood (2023) 142 (Supplement 1): 4204.

https://doi.org/10.1182/blood-2023-186378

Published: 2023

Journal Articles

Outpatient Low-Dose Venetoclax Plus Azacitidine Vs. Intensive Chemotherapy for Newly Diagnosed Fit Patients with Acute Myeloid Leukemia in a Limited Resource Setting

Yadith Karina Lopez-Garcia, Fernando De La Garza, Gerardo Alexis De la Rosa-Flores, Edgar Ulises Coronado Alejandro, Antonio Vega-Mateos, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, Valeria García-Zárate, Perla R. Rocio Colunga-Pedraza, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2023) 142 (Supplement 1): 1529.

https://doi.org/10.1182/blood-2023-188088

Published: 2023

Journal Articles

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Héctor Alejandro Vaquera Alfaro, Zulia Guzman-Martínez, Antonio Vega-Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, César Homero Gutierrez-Aguirre, Olga Cantu, David Gomez-Almaguer, Perla R. Colunga-Pedraza

Blood (2023) 142 (Supplement 1): 1711.

https://doi.org/10.1182/blood-2023-188171

Published: 2023

Journal Articles

Why Are Patients Not Getting a Graft? an Intent-to-Transplant Analysis in the Times of Universal Coverage and Haploidentical Donors

Yadith Karina Lopez-Garcia, Christianne Bourlon De Los Rios, Perla Rocio Colunga-Pedraza, Cesar Omar Vargas-Serafin, Alberto Vazquez Mellado de Larracoechea, Lourdes Gil-Flores, Nidia Moncada Saucedo, Moisés Manuel Gallardo-Pérez, David Gomez-Almaguer, Guillermo José Ruiz-Argüelles, Andres Gomez-De Leon

Blood (2022) 140 (Supplement 1): 2419–2420.

https://doi.org/10.1182/blood-2022-167805

Published: 2022

Journal Articles

Are Delays in the Diagnosis and Treatment of Acute Leukemia in a Middle-Income Country Associated with Poor Outcomes?

Yadith Karina López García, Mayra Valdez-Carrizales, Jorge Adrian Nuñez-Zuno, Elia Ixel Apodaca, Juan Rangel-Patiño, Roberta Demichelis

Blood (2021) 138 (Supplement 1): 5008.

https://doi.org/10.1182/blood-2021-148056

Published: 2021

Journal Articles

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Perla Rocio Colunga Pedraza, MD, Andres Gomez De Leon, MD, Guillermo Sotomayor Duque, MD, Julia Esther Colunga Pedraza, MD, Yadith Karina López García, Paola Santana-Hernandez, Cesar Homero Gutierrez Aguirre, Olga Cantu Rodriguez, MD, Luz del Carmen Tarín Arzaga, MD, Oscar Gonzalez Llano, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 1940.

https://doi.org/10.1182/blood.V130.Suppl_1.1940.1940

Published: 2017

NARROW

Effectiveness of Single-Dose Plerixafor in Enhancing Peripheral Blood Progenitor Cell Yield and Rate of Second Collection in Autologous Transplant

Efficacy of Outpatient Haploidentical Transplantation in Patients with Refractory Hodgkin Lymphoma

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Low-Dose Venetoclax with Azacitidine in Adults with Acute Myeloid Leukemia: Impact of Phenotype on Outcomes

Therapy Based on Attenuated Arsenic Trioxide Plus Low-Dose All-Trans-Retinoic Acid in Acute Promyelocytic Leukemia. Is Less More?

Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study

Identifying Barriers to Sexual Health in Patients with Hematological Malignancies and Underprivileged Circumstances

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

The Impact of Adding Rituximab to the Standard Chemotherapy + TKI Regimen in Adults with Philadelphia-Positive B Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study

Outpatient Low-Dose Venetoclax Plus Azacitidine Vs. Intensive Chemotherapy for Newly Diagnosed Fit Patients with Acute Myeloid Leukemia in a Limited Resource Setting

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Why Are Patients Not Getting a Graft? an Intent-to-Transplant Analysis in the Times of Universal Coverage and Haploidentical Donors

Are Delays in the Diagnosis and Treatment of Acute Leukemia in a Middle-Income Country Associated with Poor Outcomes?

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only